Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Pharmacist Education in Biosimilars (Western Europe, Canada, Japan)
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Biosimilars in Hematologic Malignancies & Supportive Care
Release Date:
Review Process: Pfizer Internal
Education Oncology All
The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Advances in Atopic Dermatitis for Advanced Practitioners
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
2020 RD US- Next Generation PET Imaging for ATTR-CM
Release Date:
Partner: GE Healthcare
Review Process: Expert Review Panel
Research Rare Disease USA
Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program
Release Date:
Partner: International Society of Amyloidosis
Review Process: Expert Review Panel
Fellowship Rare Disease All
Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment
Release Date:
Partner: Mayo Clinic/Global Bridges
Review Process: Expert Review Panel
Education Internal Medicine China, Malaysia, Taiwan, Thailand
2021 Rheumatology Competitive Grant Program
Release Date:
Review Process: Expert Review Panel
Research Inflammation & Immunology USA
4th Quality Improvement initiatives optimizing AF and VTE management in Canada
Release Date:
Partner: Bristol-Myers Squibb
Review Process: Pfizer Internal
Quality Improvement Internal Medicine Canada